Shares of Devyani International listed at a premium of more than 56% to their offer price while the other three companies that debuted alon...

Four debutantes received a mixed response on Dalal Street. Devyani International and Exxaro Tiles gave decent gains on day one, whereas Win...

Astha Jain of Hem Securities suggested that investors should book partial profits in Krsnaa Diagnostics and Exxaro Tiles.

The IPO by the Dehradun-based pharma formulations company ran from August 4 to August 6 and was sold in the Rs 448-460 range.

Premia of these listing candidates in the unofficial market were hammered badly after sentiment in the second rung stocks took a hit, subsc...

The three-day IPO received bids for 13,77,39,750 shares against 61,36,252 shares on offer, as per NSE data.

The ₹1,838-crore issue of Devyani International, the operator of quick-service restaurants (QSRs) such as KFC, Costa Coffee and Pizza Hut, ...

The company has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according ...

Larger issues like Devyani International is commanding a premium of 70-75 per cent, or Rs 63-65, over its price band of Rs 86-90, whereas K...

Windlas Biotech has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, accord...

The average listing day gains of five IPOs in July was 76%. Tatva Chintan Pharma listed at a premium of 113%, GR Infraprojects rallied 109%...

The Rs 401 crore issue received applications for 63,38,730 shares out of on-offer 61,36,252 shares, meaning a subscription of slightly over...

The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...

They include Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech, which are going to raise close to Rs 3,614 crore ...

Analysts and traders expect the issues to sail through given the demand for fresh issues in the market. The grey market premium has also ju...

Companies usually time their IPO launches based on the market sentiment and investor appetite for these share sales. Bankers said if the mo...

The company is into domestic pharmaceutical formulations contract development and manufacturing business.